Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management
The objective of this paper is to evaluate available evidence for each step in autoimmune
encephalitis management and provide expert opinion when evidence is lacking. The paper …
encephalitis management and provide expert opinion when evidence is lacking. The paper …
Autoimmune encephalitis: clinical spectrum and management
Autoimmune encephalitis defines brain inflammation caused by a misdirected immune
response against self-antigens expressed in the central nervous system. It comprises a …
response against self-antigens expressed in the central nervous system. It comprises a …
Single-cell transcriptomics and surface epitope detection in human brain epileptic lesions identifies pro-inflammatory signaling
P Kumar, A Lim, SN Hazirah, CJH Chua, A Ngoh… - Nature …, 2022 - nature.com
Epileptogenic triggers are multifactorial and not well understood. Here we aimed to address
the hypothesis that inappropriate pro-inflammatory mechanisms contribute to the …
the hypothesis that inappropriate pro-inflammatory mechanisms contribute to the …
Rituximab treatment and long-term outcome of patients with autoimmune encephalitis: real-world evidence from the GENERATE registry
FS Thaler, L Zimmermann… - Neurology …, 2021 - AAN Enterprises
Background and Objectives To determine the real-world use of rituximab in autoimmune
encephalitis (AE) and to correlate rituximab treatment with the long-term outcome. Methods …
encephalitis (AE) and to correlate rituximab treatment with the long-term outcome. Methods …
Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes
Seronegative autoimmune encephalitis is autoimmune encephalitis without any identifiable
pathogenic antibody. Although it is a major subtype of autoimmune encephalitis, many …
pathogenic antibody. Although it is a major subtype of autoimmune encephalitis, many …
LGI1 antibody encephalitis: acute treatment comparisons and outcome
A Rodriguez, CJ Klein, E Sechi, E Alden… - Journal of Neurology …, 2022 - jnnp.bmj.com
Objective To compare acute treatment responses and long-term outcome in leucine-rich
glioma-inactivated 1 (LGI1) antibody encephalitis. Methods Retrospective case series of 118 …
glioma-inactivated 1 (LGI1) antibody encephalitis. Methods Retrospective case series of 118 …
Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management
The objective of this paper is to evaluate available evidence for each step in autoimmune
encephalitis management and provide expert opinion when evidence is lacking. The paper …
encephalitis management and provide expert opinion when evidence is lacking. The paper …
Anti-NMDA receptor autoimmune encephalitis: diagnosis and management strategies
L Nguyen, C Wang - International journal of general medicine, 2023 - Taylor & Francis
Abstract Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is the most recognized
form of autoimmune encephalitis. It is characterized by a constellation of neurologic and …
form of autoimmune encephalitis. It is characterized by a constellation of neurologic and …
Antibody-mediated autoimmune diseases of the CNS: challenges and approaches to diagnosis and management
E Sechi, EP Flanagan - Frontiers in neurology, 2021 - frontiersin.org
Antibody-mediated disorders of the central nervous system (CNS) are increasingly
recognized as neurologic disorders that can be severe and even life-threatening but with the …
recognized as neurologic disorders that can be severe and even life-threatening but with the …